Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: Assessment by μCT, histology, and serum biomarkers

References

• Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000; 43:250–258.
   PubMed Web of Science ®Google Scholar
• Katz Y, Nadiv O, Rapoport MJ, Loos M. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin Exp Immunol. 2000; 120:22–29.
   PubMedGoogle Scholar
• Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum. 1985; 28:25–31.
   PubMedGoogle Scholar
• Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T, Koshihara Y. A new mechanism of bone destruction in rheumatoid arthritis: Synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun. 1997; 240:279–286.
   PubMed Web of Science ®Google Scholar
• Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997; 61:1861–1878.
   PubMed Web of Science ®Google Scholar
• Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology. 2005; 12:167–181.
   PubMedGoogle Scholar
• Herman S, Kronke G, Schett G. Molecular mechanisms of inflammatory bone damage: Emerging targets for therapy. Trends Mol Med. 2008; 14:245–253.
   PubMed Web of Science ®Google Scholar
• Romas E, Gillespie MT. Inflammation-induced bone loss: Can it be prevented?. Rheum Dis Clin North Am. 2006; 32:759–773.
   PubMed Web of Science ®Google Scholar
• van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI. Amplifying elements of arthritis and joint destruction. Ann Rheum Dis. 2007; 66 Suppl 3: iii45–iii48.
   PubMedGoogle Scholar
• Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA. Synovial fluid macrophages are capable of osteoclast formation and resorption. J Pathol. 2006; 208:35–43.
   PubMed Web of Science ®Google Scholar
• Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, . Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93:165–176.
   PubMed Web of Science ®Google Scholar
• Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, . RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res. 2005; 20:1756–1765.
   PubMed Web of Science ®Google Scholar
• Ziolkowska M, Kurowska M, Radzikowska A, Luszczykiewicz G, Wiland P, Dziewczopolski W, . High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. Arthritis Rheum. 2002; 46:1744–1753.
   PubMed Web of Science ®Google Scholar
• Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS. Mechanisms of disease: The link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol. 2005; 1:47–54.
   PubMedGoogle Scholar
• Silva MD, Savinainen A, Kapadia R, Ruan J, Siebert E, Avitahl N, . Quantitative analysis of micro-CT imaging and histopathological signatures of experimental arthritis in rats. Mol Imag. 2004; 3:312–318.
   PubMedGoogle Scholar
• Martin-Badosa E, Amblard D, Nuzzo S, Elmoutaouakkil A, Vico L, Peyrin F. Excised bone structures in mice: Imaging at three-dimensional synchrotron radiation micro CT. Radiology. 2003; 229:921–928.
   PubMed Web of Science ®Google Scholar
• Barck KH, Lee WP, Diehl LJ, Ross J, Gribling P, Zhang Y, . Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum. 2004; 50:3377–3386.
   PubMedGoogle Scholar
• Nishida S, Tsurukami H, Sakai A, Sakata T, Ikeda S, Tanaka M, . Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice. Bone. 2002; 30:872–879.
   PubMedGoogle Scholar
• Barbier A, Martel C, de Vernejoul MC, Tirode F, Nys M, Mocaer G, . The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography. J Bone Miner Metab. 1999; 17:37–44.
   PubMed Web of Science ®Google Scholar
• Balto K, Muller R, Carrington DC, Dobeck J, Stashenko P. Quantification of periapical bone destruction in mice by micro-computed tomography. J Dent Res. 2000; 79:35–40.
   PubMed Web of Science ®Google Scholar
• Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells. 2005; 19:180–184.
   PubMed Web of Science ®Google Scholar
• Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford). 2001; 40:522–527.
   PubMed Web of Science ®Google Scholar
• Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, . Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2003; 48:339–347.
   PubMed Web of Science ®Google Scholar
• Page G, Sattler A, Kersten S, Thiel A, Radbruch A, Miossec P. Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am J Pathol. 2004; 164:409–417.
   PubMed Web of Science ®Google Scholar
• Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol. 1999; 162:1246–1251.
   PubMed Web of Science ®Google Scholar
• Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, . High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000; 164:2832–2838.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, . Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999; 42:963–970.
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, . IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999; 103:1345–1352.
   PubMed Web of Science ®Google Scholar
• Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, . Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol. 2005; 167:141–149.
   PubMed Web of Science ®Google Scholar
• van den Berg WB, Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol. 2009; 5:549–553.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arthritis Res Ther. 2005; 7:29–37.
   PubMed Web of Science ®Google Scholar
• Xing L, Schwarz EM, Boyce BF. Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev. 2005; 208:19–29.
   PubMed Web of Science ®Google Scholar
• Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis. 1994; 53:39–44.
   PubMed Web of Science ®Google Scholar
• Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis. 1996; 55:816–822.
   PubMed Web of Science ®Google Scholar
• Itonaga I, Fujikawa Y, Sabokbar A, Murray DW, Athanasou NA. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent. J Pathol. 2000; 192:97–104.
   PubMed Web of Science ®Google Scholar
• Danks L, Sabokbar A, Gundle R, Athanasou NA. Synovial macrophage–osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis. 2002; 61:916–921.
   PubMedGoogle Scholar
• Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res. 2002; 4:281–289.
   PubMedGoogle Scholar